Document Detail


The Discovery of Phthalazinone-Based Human H(1) and H(3) Single-Ligand Antagonists Suitable for Intranasal Administration for the Treatment of Allergic Rhinitis.
MedLine Citation:
PMID:  21381763     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
A series of potent phthalazinone-based human H(1) and H(3) bivalent histamine receptor antagonists, suitable for intranasal administration for the potential treatment of allergic rhinitis, were identified. Blockade of H(3) receptors is thought to improve efficacy on nasal congestion, a symptom of allergic rhinitis that is currently not treated by current antihistamines. Two analogues (56a and 56b) had slightly lower H(1) potency (pA(2) 9.1 and 8.9, respectively, vs 9.7 for the clinical gold-standard azelastine, and H(3) potency (pK(i) 9.6 and 9.5, respectively, vs 6.8 for azelastine). Compound 56a had longer duration of action than azelastine, low brain penetration, and low oral bioavailability, which coupled with the predicted low clinical dose, should limit the potential of engaging CNS-related side-effects associated with H(1) or H(3) antagonism.
Authors:
Panayiotis A Procopiou; Christopher Browning; Jennifer M Buckley; Kenneth L Clark; Lise Fechner; Paul M Gore; Ashley P Hancock; Simon T Hodgson; Duncan S Holmes; Michael Kranz; Brian E Looker; Karen M L Morriss; Daniel L Parton; Linda J Russell; Robert J Slack; Steven L Sollis; Sadie Vile; Clarissa J Watts
Related Documents :
8295723 - Upregulation of a1 adenosine receptors in human temporal lobe epilepsy: a quantitative ...
16386423 - Synthesis and preliminary evaluation of new 1- and 3-[1-(2-hydroxy-3-phenoxypropyl)]xan...
20877713 - Broca's region: novel organizational principles and multiple receptor mapping.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-7
Journal Detail:
Title:  Journal of medicinal chemistry     Volume:  -     ISSN:  1520-4804     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9716531     Medline TA:  J Med Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Departments of Medicinal Chemistry, ‡Respiratory Biology, §Drug Metabolism and Pharmacokinetics, and ∥Cheminformatics, GlaxoSmithKline Medicines Research Centre , Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Synthesis and Biological Evaluation of 3,7-Diazabicyclo[4.3.0]nonan-8-ones as Potential Nootropic an...
Next Document:  Asymmetric Synthesis of Pyrrolo[2,1-a]isoquinoline Derivatives by 1,3-Dipolar Cycloadditions of Stab...